(Q45878878)

17 December 2017

title

Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma (English)

1 reference

17 December 2017

0 references

8

Brenner MK

1 reference

17 December 2017

author name string

Takahashi S

1

1 reference

17 December 2017

Yotnda P

2

1 reference

17 December 2017

Rousseau RF

3

1 reference

17 December 2017

Mei Z

4

1 reference

17 December 2017

Smith S

5

1 reference

17 December 2017

Rill D

6

1 reference

17 December 2017

Younes A

7

1 reference

17 December 2017

publication date

1 May 2001

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

378-387

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700315

exact match

0 references

cites work

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Immunotherapy in conjunction with autologous and allogeneic blood or marrow transplantation in lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

CD40-CD40 ligand interactions stimulate B cell antigen processing.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Human adenovirus vectors for gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Adenovirus vectors for gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700315

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700315

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017